BR112017006307A2 - efeitos antivirais de narasina na ração suína - Google Patents

efeitos antivirais de narasina na ração suína

Info

Publication number
BR112017006307A2
BR112017006307A2 BR112017006307A BR112017006307A BR112017006307A2 BR 112017006307 A2 BR112017006307 A2 BR 112017006307A2 BR 112017006307 A BR112017006307 A BR 112017006307A BR 112017006307 A BR112017006307 A BR 112017006307A BR 112017006307 A2 BR112017006307 A2 BR 112017006307A2
Authority
BR
Brazil
Prior art keywords
narasin
swine
composition
pigs
antiviral effects
Prior art date
Application number
BR112017006307A
Other languages
English (en)
Inventor
Leigh Puls Christopher
Granville Owens Jane
Shern Rosenkrans Kelly
John RITTER Matthew
Alan Marsteller Thomas
Edmund Weber Thomas
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR112017006307A2 publication Critical patent/BR112017006307A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

a presente invenção refere-se a uma composição para melhorar infecções virais em porcos de criadouro. a composição contém a narasina ionóforo de poliéter e é fornecida aos porcos de criadouro em uma forma oralmente aceitável. a composição é eficaz na redução da disseminação viral e da gravidade da diarreia depois do teste de porcos de criadouro com o vírus de diarreia epidêmica suína (pedv).
BR112017006307A 2014-11-13 2015-11-10 efeitos antivirais de narasina na ração suína BR112017006307A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462079159P 2014-11-13 2014-11-13
PCT/US2015/059848 WO2016077282A1 (en) 2014-11-13 2015-11-10 Antiviral effects of narasin in swine feed

Publications (1)

Publication Number Publication Date
BR112017006307A2 true BR112017006307A2 (pt) 2017-12-12

Family

ID=54782806

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017006307A BR112017006307A2 (pt) 2014-11-13 2015-11-10 efeitos antivirais de narasina na ração suína

Country Status (17)

Country Link
US (2) US20170296504A1 (pt)
EP (1) EP3217971B1 (pt)
JP (1) JP6276469B2 (pt)
KR (1) KR101929141B1 (pt)
CN (1) CN107106534B (pt)
AU (1) AU2015346616B2 (pt)
BR (1) BR112017006307A2 (pt)
CA (1) CA2963476C (pt)
CL (1) CL2017001207A1 (pt)
EA (1) EA031870B1 (pt)
ES (1) ES2754354T3 (pt)
MX (1) MX2017006264A (pt)
NZ (1) NZ730374A (pt)
PL (1) PL3217971T3 (pt)
PT (1) PT3217971T (pt)
TW (1) TWI656872B (pt)
WO (1) WO2016077282A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021019351A2 (pt) 2019-03-28 2021-12-07 Academia Sinica Bidens pilosa e seus fitoquímicos para uso na prevenção e tratamento de diarreia
WO2021240375A1 (en) * 2020-05-26 2021-12-02 Blueprint Pharma S.R.L. Methotrexate for use in the pharmaceutical or veterinary prevention and/or treatment of viral infections
IT202000012325A1 (it) * 2020-05-26 2021-11-26 Blueprint Pharma Srl Metotrexato per l’uso nel trattamento di infezioni virali in animali da allevamento
CN112843043B (zh) * 2021-02-20 2023-03-14 华中农业大学 盐霉素在制备抗冠状病毒药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038384A (en) 1974-06-10 1977-07-26 Eli Lilly And Company Antibiotic a-28086 and process for production thereof
US3995027A (en) * 1975-06-04 1976-11-30 Eli Lilly And Company Anti-viral method in animals
US4174404A (en) * 1977-10-20 1979-11-13 Eli Lilly And Company Deoxynarasin antibiotics
US4309504A (en) 1980-01-28 1982-01-05 Eli Lilly And Company Process for preparing narasin
US4342829A (en) 1981-05-06 1982-08-03 Eli Lilly And Company Process for preparing narasin
US4824829A (en) * 1984-08-15 1989-04-25 American Cyanamid Company Non-dusting antibiotic, anticoccidial premix compositions and a process for their manufacture
US5834473A (en) * 1993-04-29 1998-11-10 Cultor, Ltd. Method for treating coccidiosis
JPH08509372A (ja) * 1993-04-29 1996-10-08 クルトル リミテッド コクシジウム症の動物に投与するための組成物
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
KR101140582B1 (ko) * 2009-10-09 2012-05-09 주식회사 옵티팜솔루션 음양곽 추출물을 포함하는 돼지유행성설사병 예방 또는 치료용 조성물
JP2016507532A (ja) * 2013-02-08 2016-03-10 ルオダ ファーマ ピーティーワイ リミテッド 局所微生物感染を処置する方法

Also Published As

Publication number Publication date
MX2017006264A (es) 2017-08-14
EA201790831A1 (ru) 2017-09-29
CL2017001207A1 (es) 2018-01-12
TWI656872B (zh) 2019-04-21
CN107106534B (zh) 2020-01-21
CA2963476A1 (en) 2016-05-19
TW201628611A (zh) 2016-08-16
EP3217971A1 (en) 2017-09-20
CN107106534A (zh) 2017-08-29
US20220265597A1 (en) 2022-08-25
EP3217971B1 (en) 2019-09-11
JP2017536345A (ja) 2017-12-07
JP6276469B2 (ja) 2018-02-07
PT3217971T (pt) 2019-11-20
KR20170066622A (ko) 2017-06-14
AU2015346616B2 (en) 2018-03-01
US20170296504A1 (en) 2017-10-19
ES2754354T3 (es) 2020-04-17
CA2963476C (en) 2019-05-21
WO2016077282A1 (en) 2016-05-19
EA031870B1 (ru) 2019-03-29
PL3217971T3 (pl) 2020-03-31
AU2015346616A1 (en) 2017-04-13
NZ730374A (en) 2018-10-26
KR101929141B1 (ko) 2018-12-13

Similar Documents

Publication Publication Date Title
BR112017006307A2 (pt) efeitos antivirais de narasina na ração suína
IL268480B (en) Testing light masks by comparing two light masks
CL2018002334A1 (es) Moduladores de complementos factor b (divisional solicitud 201600606)
BR112018074658A2 (pt) multicast e/ou broadcast para comunicações do tipo máquina aperfeiçoada e/ou internet de coisas de banda estreita
BR112016002081A2 (pt) composições de limpeza contendo uma poliéter amina
CL2016001706A1 (es) Compuestos de nicotinamida sustituida con heteroarilo
AR095232A1 (es) Métodos y composiciones para el control de malezas
BR112017003711A2 (pt) artigo do tipo para vestir com cós elástico
BR112017025864A2 (pt) ?dispositivo para medir aspereza e brilho do cabelo, método para avaliar o estado do cabelo, kit e embalagem?
CR20160400A (es) Derivados de nucleosido sustituidos con 4´-difluorometilo como inhibidores de la replicación de arn de la influenza
BR112018006100A2 (pt) método e aparelho para deduplicação de linha de cache por meio de correspondência de dados
CL2016000392A1 (es) Análogos de cortistatina para el tratamiento de enfermedades con componente inflamatorio y/o inmune
BR112015020506A2 (pt) lâmina de turbina
BR112014032516A2 (pt) método e dispositivo para processamento de imagem
BR112015022535A2 (pt) método implementado por computador, sistema, aparelho e mídia legível por computador não transitória
BR112016024601A2 (pt) composições de siloxano e métodos para reduzir voc e poeira de siloxano
BR112015031159A2 (pt) sistema cimentício compreendendo partículas de acelerador revestidas com goma-laca reticulada
BR112015028481A2 (pt) composição de borracha de alta processabilidade para pneumático adaptado para uma rodagem sem pressão
UY36204A (es) Derivados de insoindolina.
BR112015028066A2 (pt) embarcação com plataforma de popa
BR112018009066A2 (pt) copolímero de propileno heterofásico, composição de poliolefina, artigo automotivo, processo para preparação de uma composição de poliolefina, e, uso de um copolímero de propileno heterofásico.
BR112017027266A2 (pt) conduto valvulado e método para fabricação do mesmo
BR112016028518A2 (pt) composições farmacêuticas que compreendem dgla e uso do mesmo
BR112015019220A2 (pt) uso de um inibidor de helicase-primase; uso de uma composição farmacêutica; e composição farmacêutica
AR108890A1 (es) Inhibidores de la entrada del cmvh

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: ELANCO US INC. (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]